Published in Cell Tissue Bank on June 28, 2011
Limited predictability of postmortem human brain tissue quality by RNA integrity numbers. J Neurochem (2016) 0.76
An International Survey of Brain Banking Operation and Characterization Practices. Biopreserv Biobank (2016) 0.75
Quantification of nucleic acid quality in postmortem tissues from a cancer research autopsy program. Oncotarget (2016) 0.75
The RIN: an RNA integrity number for assigning integrity values to RNA measurements. BMC Mol Biol (2006) 13.13
Evaluating RNA status for RT-PCR in extracts of postmortem human brain tissue. Biotechniques (2004) 4.48
Human postmortem tissue: what quality markers matter? Brain Res (2006) 2.92
Effect of agonal and postmortem factors on gene expression profile: quality control in microarray analyses of postmortem human brain. Biol Psychiatry (2004) 2.53
The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: selective mRNA vulnerability and comparison with their encoded proteins. Neurosci Lett (1995) 2.35
Systematic changes in gene expression in postmortem human brains associated with tissue pH and terminal medical conditions. Hum Mol Genet (2004) 2.33
Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res (1995) 1.98
Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology. J Neurosci Methods (2007) 1.44
Brain pH has a significant impact on human postmortem hippocampal gene expression profiles. Brain Res (2006) 1.31
Selection of reference gene expression in a schizophrenia brain cohort. Aust N Z J Psychiatry (2010) 1.30
The pathogenesis of acute selective necrosis of the granular layer of the human cerebellar cortex. Acta Neuropathol (1977) 1.18
Tissue preparation and banking. Prog Brain Res (2006) 1.16
AN EXPERIMENTAL STUDY OF POST-MORTEM ALTERATIONS IN THE GRANULAR LAYER OF THE CEREBELLAR CORTEX. J Neuropathol Exp Neurol (1963) 1.15
An Australian Brain Bank: a critical investment with a high return! Cell Tissue Bank (2008) 1.13
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortium. Neuropathol Appl Neurobiol (2009) 1.13
Autolysis of the granular layer of the cerebellar cortex in brain death. Acta Neuropathol (1986) 0.93
Phosphatidylinositol kinase is reduced in Alzheimer's disease. J Neurochem (1992) 0.91
Naphthylamidase used as a lysosome marker in the study of acute selective necrosis of the internal granular layer of cerebellum. Acta Pathol Microbiol Scand A (1977) 0.79
A study of the rate of cell depletion in solid tissue. J Pathol (1980) 0.79
Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat Genet (2010) 5.52
Clinicopathological correlates in frontotemporal dementia. Ann Neurol (2004) 4.38
The pathological basis of semantic dementia. Brain (2005) 2.96
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol (2010) 2.30
Neuropathologic correlates of white matter hyperintensities. Neurology (2008) 2.29
Multiple biological pathways link cognitive lifestyle to protection from dementia. Biol Psychiatry (2011) 1.79
In vivo identification of human cortical areas using high-resolution MRI: an approach to cerebral structure-function correlation. Proc Natl Acad Sci U S A (2003) 1.72
Small-vessel disease in patients with Parkinson's disease: a clinicopathological study. Mov Disord (2012) 1.56
Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol (2006) 1.47
Argyrophilic staining of nucleolar organizer region count and morphometry in benign and malignant melanocytic lesions. Am J Dermatopathol (2003) 1.44
Clinical significance of lobar atrophy in frontotemporal dementia: application of an MRI visual rating scale. Dement Geriatr Cogn Disord (2007) 1.39
Serotoninergic receptor 1A in the sudden infant death syndrome brainstem medulla and associations with clinical risk factors. Acta Neuropathol (2008) 1.36
Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J Infect Dis (2004) 1.27
Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer's disease models. Proc Natl Acad Sci U S A (2010) 1.24
Regional and cellular pathology in frontotemporal dementia: relationship to stage of disease in cases with and without Pick bodies. Acta Neuropathol (2004) 1.19
Subcortical vascular disease and functional decline: a 6-year predictor study. J Am Geriatr Soc (2002) 1.11
Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. Brain (2003) 1.06
Functions of the novel RhoGAP proteins RGA-3 and RGA-4 in the germ line and in the early embryo of C. elegans. Development (2007) 1.05
Human alcohol-related neuropathology. Acta Neuropathol (2013) 1.04
Mitochondrial genome organization and phylogeny of two vespid wasps. Genome (2008) 1.03
Genetic and clinical features of progranulin-associated frontotemporal lobar degeneration. Arch Neurol (2011) 1.01
Understanding the pathogenesis of Alzheimer's disease: will RNA-Seq realize the promise of transcriptomics? J Neurochem (2011) 0.98
Tau-mediated nuclear depletion and cytoplasmic accumulation of SFPQ in Alzheimer's and Pick's disease. PLoS One (2012) 0.97
Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson's disease. Mov Disord (2007) 0.95
Variable phenotype of Alzheimer's disease with spastic paraparesis. J Neurochem (2007) 0.94
Differences in regional brain atrophy in genetic forms of Alzheimer's disease. Neurobiol Aging (2006) 0.94
Pick bodies in a family with presenilin-1 Alzheimer's disease. Ann Neurol (2005) 0.90
Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy. Mov Disord (2010) 0.89
Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains. J Neural Transm (Vienna) (2009) 0.89
The importance of brain banks for molecular neuropathological research: The New South Wales Tissue Resource Centre experience. Int J Mol Sci (2009) 0.89
The case of a 48 year-old woman with bizarre and complex delusions. Nat Rev Neurol (2010) 0.89
Positional effects of presenilin-1 mutations on tau phosphorylation in cortical plaques. Neurobiol Dis (2004) 0.87
Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons. PLoS One (2011) 0.87
The neural basis of semantic memory: evidence from semantic dementia. Neurobiol Aging (2008) 0.86
Knowing me, knowing you: can a knowledge of risk factors for Alzheimer's disease prove useful in understanding the pathogenesis of Parkinson's disease? J Alzheimers Dis (2011) 0.85
Using autopsy brain tissue to study alcohol-related brain damage in the genomic age. Alcohol Clin Exp Res (2013) 0.85
Influence of liver pathology on markers of postmortem brain tissue quality. Alcohol Clin Exp Res (2011) 0.84
Alzheimer disease: Alzheimer disease neuropathology in the oldest old. Nat Rev Neurol (2009) 0.83
Alzheimer's disease with spastic paraparesis and 'cotton wool' plaques: two pedigrees with PS-1 exon 9 deletions. Brain (2003) 0.82
Contributions of age and alcohol consumption to cerebellar integrity, gait and cognition in non-demented very old individuals. Eur Arch Psychiatry Clin Neurosci (2006) 0.81
Identification of families with cortical Lewy body disease. Am J Med Genet B Neuropsychiatr Genet (2004) 0.80
Staging disease severity in movement disorder tauopathies: brain atrophy separates progressive supranuclear palsy from corticobasal degeneration. Mov Disord (2005) 0.80
Microglial proliferation in the brain of chronic alcoholics with hepatic encephalopathy. Metab Brain Dis (2013) 0.80
Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson's disease. Am J Med Genet B Neuropsychiatr Genet (2008) 0.80
Very early-onset frontotemporal dementia with no family history predicts underlying fused in sarcoma pathology. Brain (2010) 0.80
Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels. J Alzheimers Dis (2013) 0.78
Classification of FTLD-TDP cases into pathological subtypes using antibodies against phosphorylated and non-phosphorylated TDP43. Acta Neuropathol Commun (2013) 0.78
Differentiating benign nevi from malignant melanoma using DNA microdensitometry and karyometry and maturation: a zonal comparison, correlation and multivariate analysis. Anal Quant Cytol Histol (2002) 0.77
Comorbidities, confounders, and the white matter transcriptome in chronic alcoholism. Alcohol Clin Exp Res (2014) 0.77
Neuropathology in the S305S tau gene mutation. Brain (2006) 0.77
The pathogenesis of cingulate atrophy in behavioral variant frontotemporal dementia and Alzheimer's disease. Acta Neuropathol Commun (2013) 0.77
Tau isoform expression in frontotemporal dementia without tau deposition. J Clin Neurosci (2007) 0.76
Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease. Int Psychogeriatr (2009) 0.76
The alternative splicing of the apolipoprotein E gene is unperturbed in the brains of Alzheimer's disease patients. Mol Biol Rep (2014) 0.76
Overview and recent advances in neuropathology. Part 2: Neurodegeneration. Pathology (2011) 0.75
Families' reflections on the process of brain donation following coronial autopsy. Cell Tissue Bank (2010) 0.75
Melanin bleaching in argyrophilic staining of AgNORs in pigmented lesions: a morphometric evaluation. Anal Quant Cytol Histol (2002) 0.75
Effects of cigarette smoke exposure on nicotinic acetylcholine receptor subunits α7 and β2 in the sudden infant death syndrome (SIDS) brainstem. Toxicol Appl Pharmacol (2011) 0.75
Preserved cognition and functional independence after a large right posterior cerebral artery infarct: longitudinal clinical and neuropathological findings. Neurocase (2006) 0.75